2023-2029 Global Blood Pressure Medications Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 150 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Blood Pressure Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Blood Pressure Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Blood Pressure Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Calcium Channel Blockers segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Blood Pressure Medications include Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals and Huahai Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report aims to provide a comprehensive study of the global market for Blood Pressure Medications. Report Highlights:
(1) Global Blood Pressure Medications market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Blood Pressure Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Blood Pressure Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Blood Pressure Medications segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Blood Pressure Medications segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Blood Pressure Medications, capacity, production and trends.
(7) Blood Pressure Medications industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Compound Drugs
Diuretics
Others
Market segment by application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Medicine

1 Market Overview
1.1 Blood Pressure Medications Definition
1.2 Global Blood Pressure Medications Market Size and Forecast
1.2.1 By Revenue, Global Blood Pressure Medications Market Size, 2018-2029
1.2.2 By Sales Volume, Global Blood Pressure Medications Market Size, 2018-2029
1.2.3 Global Blood Pressure Medications Price Trend, 2018-2029
1.3 China Blood Pressure Medications Market Size and Forecast
1.3.1 By Revenue, China Blood Pressure Medications Market Size, 2018-2029
1.3.2 By Sales Volume, China Blood Pressure Medications Market Size, 2018-2029
1.3.3 China Blood Pressure Medications Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Blood Pressure Medications Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Blood Pressure Medications Share in Global Market, 2018-2029
1.4.3 Blood Pressure Medications Market Size: China VS Global, 2018-2029
1.5 Blood Pressure Medications Market Dynamics
1.5.1 Blood Pressure Medications Market Drivers
1.5.2 Blood Pressure Medications Market Restraints
1.5.3 Blood Pressure Medications Industry Trends
1.5.4 Blood Pressure Medications Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Blood Pressure Medications Revenue by Company, 2018-2023
2.2 Global Blood Pressure Medications Sales Volume by Company, 2018-2023
2.3 Global Blood Pressure Medications Price by Company, 2018-2023
2.4 Global Blood Pressure Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Blood Pressure Medications Concentration Ratio
2.6 Global Blood Pressure Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Blood Pressure Medications Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Blood Pressure Medications Revenue by Company, 2018-2023
3.2 China Blood Pressure Medications Sales Volume by Company, 2018-2023
3.3 China Blood Pressure Medications Blood Pressure Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Blood Pressure Medications Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Blood Pressure Medications Domestic VS Export
3.6 China Market, Blood Pressure Medications Import & Export
3.6.1 China Market, Blood Pressure Medications Import & Export, 2018-2029
3.6.2 China Blood Pressure Medications Import & Export Trends
3.6.3 Main Sources of China Blood Pressure Medications Import
3.6.4 Export Destination of China Blood Pressure Medications
4 Blood Pressure Medications Production by Region
4.1 Global Blood Pressure Medications Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Blood Pressure Medications Manufacturers
4.3 Global Major Manufacturers, Blood Pressure Medications Capacity Expansion and Future Plans
4.4 Global Blood Pressure Medications Capacity by Region
4.5 Global Blood Pressure Medications Production by Region
4.5.1 Global Blood Pressure Medications Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Blood Pressure Medications Production by Region, 2018-2023
4.5.3 Global Blood Pressure Medications Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Blood Pressure Medications Industry Chain
5.2 Blood Pressure Medications Upstream Analysis
5.2.1 Blood Pressure Medications Core Raw Materials
5.2.2 Main Manufacturers of Blood Pressure Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Blood Pressure Medications Production Mode
5.6 Blood Pressure Medications Procurement Model
5.7 Blood Pressure Medications Industry Sales Model and Sales Channels
5.7.1 Blood Pressure Medications Sales Model
5.7.2 Blood Pressure Medications Typical Distributors
6 Sights by Type
6.1 Blood Pressure Medications Classification
6.1.1 Calcium Channel Blockers
6.1.2 ACE Inhibitors
6.1.3 Angiotensin II Receptor Blockers
6.1.4 Beta Blockers
6.1.5 Compound Drugs
6.1.6 Diuretics
6.1.7 Others
6.2 By Type, Global Blood Pressure Medications Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Blood Pressure Medications Revenue, 2018-2029
6.4 By Type, Global Blood Pressure Medications Sales Volume, 2018-2029
6.5 By Type, Global Blood Pressure Medications Price, 2018-2029
7 Sights by Application
7.1 Blood Pressure Medications Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Blood Pressure Medications Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Blood Pressure Medications Revenue, 2018-2029
7.4 By Application, Global Blood Pressure Medications Sales Volume, 2018-2029
7.5 By Application, Global Blood Pressure Medications Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Blood Pressure Medications Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Blood Pressure Medications Revenue, 2018-2029
8.3 By Region, Global Blood Pressure Medications Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Blood Pressure Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Blood Pressure Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Blood Pressure Medications Market Size Market Share
8.7 South America
8.7.1 South America Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Blood Pressure Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Blood Pressure Medications Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Blood Pressure Medications Revenue, 2018-2029
9.3 By Country, Global Blood Pressure Medications Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Blood Pressure Medications Market Size, 2018-2029
9.4.2 By Company, U.S. Blood Pressure Medications Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Blood Pressure Medications Market Size, 2018-2029
9.5.2 By Company, Europe Blood Pressure Medications Sales Volume Market Share, 2022
9.5.3 By Type, Europe Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Blood Pressure Medications Market Size, 2018-2029
9.6.2 By Company, China Blood Pressure Medications Sales Volume Market Share, 2022
9.6.3 By Type, China Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Blood Pressure Medications Market Size, 2018-2029
9.7.2 By Company, Japan Blood Pressure Medications Sales Volume Market Share, 2022
9.7.3 By Type, Japan Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Blood Pressure Medications Market Size, 2018-2029
9.8.2 By Company, South Korea Blood Pressure Medications Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Blood Pressure Medications Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Blood Pressure Medications Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Blood Pressure Medications Market Size, 2018-2029
9.10.2 By Company, India Blood Pressure Medications Sales Volume Market Share, 2022
9.10.3 By Type, India Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Blood Pressure Medications Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Blood Pressure Medications Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Blood Pressure Medications Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Blood Pressure Medications Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Blood Pressure Medications Models, Specifications and Application
10.1.3 Pfizer Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis Blood Pressure Medications Models, Specifications and Application
10.2.3 Novartis Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.3.2 AstraZeneca Blood Pressure Medications Models, Specifications and Application
10.3.3 AstraZeneca Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AstraZeneca Company Profile and Main Business
10.3.5 AstraZeneca Recent Developments
10.4 Bayer
10.4.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.4.2 Bayer Blood Pressure Medications Models, Specifications and Application
10.4.3 Bayer Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Bayer Company Profile and Main Business
10.4.5 Bayer Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.5.2 Sanofi Blood Pressure Medications Models, Specifications and Application
10.5.3 Sanofi Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.6.2 Boehringer Ingelheim Blood Pressure Medications Models, Specifications and Application
10.6.3 Boehringer Ingelheim Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Boehringer Ingelheim Company Profile and Main Business
10.6.5 Boehringer Ingelheim Recent Developments
10.7 Merck
10.7.1 Merck Company Information, Head Office, Market Area and Industry Position
10.7.2 Merck Blood Pressure Medications Models, Specifications and Application
10.7.3 Merck Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Merck Company Profile and Main Business
10.7.5 Merck Recent Developments
10.8 Lupin Pharmaceuticals
10.8.1 Lupin Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.8.2 Lupin Pharmaceuticals Blood Pressure Medications Models, Specifications and Application
10.8.3 Lupin Pharmaceuticals Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Lupin Pharmaceuticals Company Profile and Main Business
10.8.5 Lupin Pharmaceuticals Recent Developments
10.9 Huahai Pharmaceutical
10.9.1 Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Huahai Pharmaceutical Blood Pressure Medications Models, Specifications and Application
10.9.3 Huahai Pharmaceutical Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Huahai Pharmaceutical Company Profile and Main Business
10.9.5 Huahai Pharmaceutical Recent Developments
10.10 Jiangsu Jibeier Pharmaceutical
10.10.1 Jiangsu Jibeier Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Models, Specifications and Application
10.10.3 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jiangsu Jibeier Pharmaceutical Company Profile and Main Business
10.10.5 Jiangsu Jibeier Pharmaceutical Recent Developments
10.11 Tianjin Pharmaceutical Da Ren Tang Group
10.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information, Head Office, Market Area and Industry Position
10.11.2 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Models, Specifications and Application
10.11.3 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Tianjin Pharmaceutical Da Ren Tang Group Company Profile and Main Business
10.11.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
10.12 Chengdu Easton Biopharmaceuticals
10.12.1 Chengdu Easton Biopharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.12.2 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Models, Specifications and Application
10.12.3 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Chengdu Easton Biopharmaceuticals Company Profile and Main Business
10.12.5 Chengdu Easton Biopharmaceuticals Recent Developments
10.13 Qingdao Huanghai Pharmaceutical
10.13.1 Qingdao Huanghai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Models, Specifications and Application
10.13.3 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Qingdao Huanghai Pharmaceutical Company Profile and Main Business
10.13.5 Qingdao Huanghai Pharmaceutical Recent Developments
10.14 CR Double-Crane
10.14.1 CR Double-Crane Company Information, Head Office, Market Area and Industry Position
10.14.2 CR Double-Crane Blood Pressure Medications Models, Specifications and Application
10.14.3 CR Double-Crane Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 CR Double-Crane Company Profile and Main Business
10.14.5 CR Double-Crane Recent Developments
10.15 Shanghai Shyndec Pharmaceutical
10.15.1 Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Models, Specifications and Application
10.15.3 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Shanghai Shyndec Pharmaceutical Company Profile and Main Business
10.15.5 Shanghai Shyndec Pharmaceutical Recent Developments
10.16 CSPC Pharmaceutical Group
10.16.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.16.2 CSPC Pharmaceutical Group Blood Pressure Medications Models, Specifications and Application
10.16.3 CSPC Pharmaceutical Group Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.16.5 CSPC Pharmaceutical Group Recent Developments
10.17 Jiangsu Hengrui Medicine
10.17.1 Jiangsu Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
10.17.2 Jiangsu Hengrui Medicine Blood Pressure Medications Models, Specifications and Application
10.17.3 Jiangsu Hengrui Medicine Blood Pressure Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Jiangsu Hengrui Medicine Company Profile and Main Business
10.17.5 Jiangsu Hengrui Medicine Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Blood Pressure Medications Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Blood Pressure Medications Market Restraints
Table 3. Blood Pressure Medications Market Trends
Table 4. Blood Pressure Medications Industry Policy
Table 5. Global Blood Pressure Medications Revenue by Company, 2018-2023, US$ million
Table 6. Global Blood Pressure Medications Revenue Market Share by Company, 2018-2023
Table 7. Global Blood Pressure Medications Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Blood Pressure Medications Sales Volume Market Share by Company, 2018-2023
Table 9. Global Blood Pressure Medications Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Blood Pressure Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Blood Pressure Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Blood Pressure Medications Manufacturers Product Type
Table 13. China Blood Pressure Medications Revenue by Company, 2018-2023, US$ million
Table 14. China Blood Pressure Medications Revenue Market Share by Company, 2018-2023
Table 15. China Blood Pressure Medications Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Blood Pressure Medications Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Blood Pressure Medications Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Blood Pressure Medications Import & Export Trends
Table 19. Main Sources of China Blood Pressure Medications Import
Table 20. Export Destination of China Blood Pressure Medications
Table 21. Global Headquarters and Manufacturing Base of Blood Pressure Medications Manufacturers
Table 22. Global Major Manufacturers, Blood Pressure Medications Capacity Expansion and Future Plans
Table 23. Global Blood Pressure Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Blood Pressure Medications Production by Region, 2018-2023, (K Units)
Table 25. Global Blood Pressure Medications Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Blood Pressure Medications Upstream (Raw Materials)
Table 27. Global Blood Pressure Medications Typical Customers
Table 28. Blood Pressure Medications Typical Distributors
Table 29. By Type, Global Blood Pressure Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Blood Pressure Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Blood Pressure Medications Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Blood Pressure Medications Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Blood Pressure Medications Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Blood Pressure Medications Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Blood Pressure Medications Revenue Market Share, 2018-2029
Table 37. By Country, Global Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Blood Pressure Medications Sales Volume Market Share, 2018-2029
Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Blood Pressure Medications Models, Specifications and Application
Table 41. Pfizer Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area and Industry Position
Table 45. Novartis Blood Pressure Medications Models, Specifications and Application
Table 46. Novartis Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 50. AstraZeneca Blood Pressure Medications Models, Specifications and Application
Table 51. AstraZeneca Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. Bayer Company Information, Head Office, Market Area and Industry Position
Table 55. Bayer Blood Pressure Medications Models, Specifications and Application
Table 56. Bayer Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Bayer Company Profile and Main Business
Table 58. Bayer Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 60. Sanofi Blood Pressure Medications Models, Specifications and Application
Table 61. Sanofi Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 65. Boehringer Ingelheim Blood Pressure Medications Models, Specifications and Application
Table 66. Boehringer Ingelheim Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Boehringer Ingelheim Company Profile and Main Business
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Merck Company Information, Head Office, Market Area and Industry Position
Table 70. Merck Blood Pressure Medications Models, Specifications and Application
Table 71. Merck Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Merck Company Profile and Main Business
Table 73. Merck Recent Developments
Table 74. Lupin Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 75. Lupin Pharmaceuticals Blood Pressure Medications Models, Specifications and Application
Table 76. Lupin Pharmaceuticals Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Lupin Pharmaceuticals Company Profile and Main Business
Table 78. Lupin Pharmaceuticals Recent Developments
Table 79. Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Huahai Pharmaceutical Blood Pressure Medications Models, Specifications and Application
Table 81. Huahai Pharmaceutical Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Huahai Pharmaceutical Company Profile and Main Business
Table 83. Huahai Pharmaceutical Recent Developments
Table 84. Jiangsu Jibeier Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Models, Specifications and Application
Table 86. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jiangsu Jibeier Pharmaceutical Company Profile and Main Business
Table 88. Jiangsu Jibeier Pharmaceutical Recent Developments
Table 89. Tianjin Pharmaceutical Da Ren Tang Group Company Information, Head Office, Market Area and Industry Position
Table 90. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Models, Specifications and Application
Table 91. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Tianjin Pharmaceutical Da Ren Tang Group Company Profile and Main Business
Table 93. Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
Table 94. Chengdu Easton Biopharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 95. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Models, Specifications and Application
Table 96. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Chengdu Easton Biopharmaceuticals Company Profile and Main Business
Table 98. Chengdu Easton Biopharmaceuticals Recent Developments
Table 99. Qingdao Huanghai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Models, Specifications and Application
Table 101. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Qingdao Huanghai Pharmaceutical Company Profile and Main Business
Table 103. Qingdao Huanghai Pharmaceutical Recent Developments
Table 104. CR Double-Crane Company Information, Head Office, Market Area and Industry Position
Table 105. CR Double-Crane Blood Pressure Medications Models, Specifications and Application
Table 106. CR Double-Crane Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. CR Double-Crane Company Profile and Main Business
Table 108. CR Double-Crane Recent Developments
Table 109. Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Models, Specifications and Application
Table 111. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Shanghai Shyndec Pharmaceutical Company Profile and Main Business
Table 113. Shanghai Shyndec Pharmaceutical Recent Developments
Table 114. CSPC Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 115. CSPC Pharmaceutical Group Blood Pressure Medications Models, Specifications and Application
Table 116. CSPC Pharmaceutical Group Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. CSPC Pharmaceutical Group Company Profile and Main Business
Table 118. CSPC Pharmaceutical Group Recent Developments
Table 119. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
Table 120. Jiangsu Hengrui Medicine Blood Pressure Medications Models, Specifications and Application
Table 121. Jiangsu Hengrui Medicine Blood Pressure Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Jiangsu Hengrui Medicine Company Profile and Main Business
Table 123. Jiangsu Hengrui Medicine Recent Developments
List of Figure
Figure 1. Blood Pressure Medications Picture
Figure 2. By Revenue, Global Blood Pressure Medications Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Blood Pressure Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Blood Pressure Medications Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Blood Pressure Medications Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Blood Pressure Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Blood Pressure Medications Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Blood Pressure Medications Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Blood Pressure Medications Share of Global Market, 2018-2029
Figure 10. Global Blood Pressure Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Blood Pressure Medications Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Blood Pressure Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Blood Pressure Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Blood Pressure Medications Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Blood Pressure Medications Domestic VS Export, 2022
Figure 16. Global Blood Pressure Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Blood Pressure Medications Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Blood Pressure Medications Production Market Share & Forecast by Region, 2018-2029
Figure 19. Blood Pressure Medications Industry Chain
Figure 20. Blood Pressure Medications Procurement Model
Figure 21. Blood Pressure Medications Sales Model
Figure 22. Blood Pressure Medications Sales Channels, Direct Sales and Distribution
Figure 23. Calcium Channel Blockers
Figure 24. ACE Inhibitors
Figure 25. Angiotensin II Receptor Blockers
Figure 26. Beta Blockers
Figure 27. Compound Drugs
Figure 28. Diuretics
Figure 29. Others
Figure 30. By Type, Global Blood Pressure Medications Revenue, 2018-2029, US$ Million
Figure 31. By Type, Global Blood Pressure Medications Revenue Market Share, 2018-2029
Figure 32. By Type, Global Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 33. By Type, Global Blood Pressure Medications Sales Volume Market Share, 2018-2029
Figure 34. By Type, Global Blood Pressure Medications Price, 2018-2029, (US$/Unit)
Figure 35. Hospital
Figure 36. Clinic
Figure 37. Others
Figure 38. By Application, Global Blood Pressure Medications Revenue, 2018-2029, US$ Million
Figure 39. By Application, Global Blood Pressure Medications Revenue Market Share, 2018-2029
Figure 40. By Application, Global Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 41. By Application, Global Blood Pressure Medications Sales Volume Market Share, 2018-2029
Figure 42. By Application, Global Blood Pressure Medications Price, 2018-2029, (US$/Unit)
Figure 43. By Region, Global Blood Pressure Medications Revenue Market Share, 2018-2029
Figure 44. By Region, Global Blood Pressure Medications Sales Volume Market Share, 2018-2029
Figure 45. North America Blood Pressure Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, North America Blood Pressure Medications Revenue Market Share, 2022
Figure 47. Europe Blood Pressure Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, Europe Blood Pressure Medications Revenue Market Share, 2022
Figure 49. Asia Pacific Blood Pressure Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country/Region, Asia Pacific Blood Pressure Medications Revenue Market Share, 2022
Figure 51. South America Blood Pressure Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. By Country, South America Blood Pressure Medications Revenue Market Share, 2022
Figure 53. Middle East & Africa Blood Pressure Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 54. U.S. Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, U.S. Blood Pressure Medications Market Share, 2022
Figure 56. By Type, U.S. Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, Europe Blood Pressure Medications Market Share, 2022
Figure 60. By Type, Europe Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 62. China Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, China Blood Pressure Medications Market Share, 2022
Figure 64. By Type, China Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, Japan Blood Pressure Medications Market Share, 2022
Figure 68. By Type, Japan Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, South Korea Blood Pressure Medications Market Share, 2022
Figure 72. By Type, South Korea Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, Southeast Asia Blood Pressure Medications Market Share, 2022
Figure 76. By Type, Southeast Asia Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, Southeast Asia Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 78. India Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, India Blood Pressure Medications Market Share, 2022
Figure 80. By Type, India Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, India Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 82. Middle East & Asia Blood Pressure Medications Sales Volume, 2018-2029, (K Units)
Figure 83. By Company, Middle East & Asia Blood Pressure Medications Market Share, 2022
Figure 84. By Type, Middle East & Asia Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 85. By Application, Middle East & Asia Blood Pressure Medications Sales Volume Market Share, 2022 VS 2029
Figure 86. Research Methodology
Figure 87. Breakdown of Primary Interviews
Figure 88. Bottom-up Approaches
Figure 89. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets